
Alibaba Health Information Technology Limited
0241.HKFinancial Statements
Income Statement (Annual)
Amounts in millions
2025
3/31/2025
Revenue
3,978
Cost of Revenue
3,012
Gross Profit
966
Gross Margin
24.3%
Operating Income
205
Operating Margin
5.2%
Net Income
186
Net Margin
4.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
211
EBITDA Margin
5.3%
2024
3/31/2024
Revenue
3,513
Cost of Revenue
2,747
Gross Profit
766
Gross Margin
21.8%
Operating Income
93
Operating Margin
2.7%
Net Income
115
Net Margin
3.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
130
EBITDA Margin
3.7%
2023
3/31/2023
Revenue
3,479
Cost of Revenue
2,738
Gross Profit
741
Gross Margin
21.3%
Operating Income
-4
Operating Margin
-0.1%
Net Income
70
Net Margin
2.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-3
EBITDA Margin
-0.1%
2022
3/31/2022
Revenue
2,675
Cost of Revenue
2,141
Gross Profit
534
Gross Margin
20.0%
Operating Income
-143
Operating Margin
-5.3%
Net Income
-35
Net Margin
-1.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-24
EBITDA Margin
-0.9%
2021
3/31/2021
Revenue
2,017
Cost of Revenue
1,547
Gross Profit
470
Gross Margin
23.3%
Operating Income
8
Operating Margin
0.4%
Net Income
45
Net Margin
2.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
7
EBITDA Margin
0.3%